BOSTON — WHOOP said it is making its Advanced Labs service available to people without a WHOOP wearable membership and is adding GRAIL’s Galleri® multi-cancer early detection test to the platform.
WHOOP Advanced Labs combines blood testing, clinician-reviewed results, AI-powered insights and personalized recommendations. In the U.S., the service is powered by Quest Diagnostics and includes comprehensive and specialized blood panels covering cardiovascular, metabolic, hormonal and inflammatory health.
Tests are reviewed and ordered by licensed healthcare providers, while reports are reviewed by clinicians and accompanied by guidance intended to help users understand their results.
“A deeper, earlier understanding of our health gives us a greater ability to shape what comes next,” said Ami Bhatt, M.D., Chief Medical Officer at WHOOP. “WHOOP Advanced Labs gives people access to comprehensive, clinically reviewed testing that often isn’t part of a routine physical and historically has been available through concierge medicine, executive physicals, or specialty clinics.”
WHOOP said Advanced Labs, which launched in 2025, has helped users identify findings including elevated cardiovascular risk, insulin resistance, prediabetes or diabetes, elevated lipoprotein(a) and hormone-related conditions. The company said testing starts at approximately $150.
As part of the expansion, WHOOP is adding Galleri, GRAIL’s multi-cancer early detection blood test, to the Advanced Labs portfolio. The test is designed to detect cancer signals associated with more than 50 types of cancer.
Galleri will be available through a single blood draw at nearly 2,000 Quest Diagnostics locations in the U.S., with testing performed at GRAIL’s laboratory in North Carolina.
Results will be delivered through the WHOOP app alongside other health information, with educational resources intended to help users understand their results and discuss appropriate next steps with a clinician.
“We’re excited to work with WHOOP to bring Galleri to a community already highly engaged in understanding, monitoring and improving their health,” said Megan Hall, Ph.D., Vice President of Medical Affairs at GRAIL. “By making multi-cancer early detection available through trusted platforms that are part of people’s everyday health journeys, we can help more people take a proactive step toward finding cancer earlier, when treatment may be more effective.”
WHOOP said the broader availability of Advanced Labs and the addition of Galleri are intended to expand access to proactive health testing beyond its existing wearable membership base.
